Etta Biotech Co. Ltd. has a founding team of 12 members with a wide range of research and business backgrounds such as RNA pharmaceutics, microelectronics, MEMS, immunotherapy, cosmetic and marketing. 6 of them possess a Ph.D degree, 2 of them are National 1000-Plan Experts and 4 are professors from top universities.
Etta Biotech possesses an intellectual property portfolio including 15 invention patents, 5 utility model patents, and 3 PCT patent applications, of which 2 have been applied to enter USA and EU.
Etta Biotech is the first Chinese company specialized in R&D of electroporation technology and products. Its cell electroporation system X-Porator H1 was launched in August 2015 and has won customers with its excellent performance such as high transfection efficiency, high cell survival rate, high single transfection volume (up to 4ml) etc.